Quadracel DTaP-IPV Vaccine for children available in US
by Press Release from Outbreak News Today on (#2B0HJ)
Sanofi Pasteur, the vaccines division of Sanofi, announced today the availability of Quadracela (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus; DTaP-IPV) vaccine in the United States. Quadracel is approved by the U.S. Food and Drug Administration (FDA) for active immunization against diphtheria, tetanus, pertussis and poliomyelitis in children 4 through 6 ["]
The post Quadracel DTaP-IPV Vaccine for children available in US appeared first on Outbreak News Today.